Additionally, exploration of newer VEGF inhibitors, some of which have demonstrated longer inhibitory activity in the treatment of retinal diseases, may offer further therapeutic potential in the context of glaucoma filtration surgery. This evidence concerns the gene VEGFA and Abnormal retinal morphology.